研究者
J-GLOBAL ID:201901012943076948
更新日: 2024年03月28日
割田 友子
ワリタ トモコ | Warita Tomoko
所属機関・部署:
職名:
講師
競争的資金等の研究課題 (3件):
- 2020 - 2023 がん代謝物に基づくスタチン適応がんの分類と微小腫瘍環境におけるスタチンの影響解析
- 2019 - 2021 スタチン高感受性がんを用いた「スタチンの効きやすさを保証する分子」の絞り込み
- 2014 - 2016 癌細胞のスタチン系薬剤感受性を決定する分子メカニズム-感受性マーカーの探索-
論文 (26件):
-
Nanami Irie, Kana Mizoguchi, Tomoko Warita, Mirai Nakano, Kasuga Sasaki, Jiro Tashiro, Tomohiro Osaki, Takuro Ishikawa, Zoltán N. Oltvai, Katsuhiko Warita. Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin-Dipyridamole Combination Treatment in Melanoma Cell Lines. Biomedicines. 2024. 12. 3. 698
-
Takuro Ishikawa, Nanami Irie, Jiro Tashiro, Tomohiro Osaki, Tomoko Warita, Katsuhiko Warita, Munekazu Naito. Comparison of the anticancer effects of various statins on canine oral melanoma cells. Veterinary and Comparative Oncology. 2024. 22. 1. 156-161
-
Cahyadi DD, Warita T, Irie N, Mizoguchi K, Tashiro J, Hosaka YZ, Warita K. Housekeeping gene expression variability in differentiating and non-differentiating 3T3-L1 cells. Adipocyte. 2023. 1. 2235081
-
Jiro Tashiro, Akihiro Sugiura, Tomoko Warita, Nanami Irie, Danang Dwi Cahyadi, Takuro Ishikawa, Katsuhiko Warita. CYP11A1 silencing suppresses HMGCR expression via cholesterol accumulation and sensitizes CRPC cell line DU-145 to atorvastatin. Journal of Pharmacological Sciences. 2023. 153. 104-112
-
Yaxuan Zhou, Jiro Tashiro, Shiori Kamatani, Nanami Irie, Akito Suzuki, Takuro Ishikawa, Katsuhiko Warita, Zoltán N. Oltvai, Tomoko Warita. HMG-CoA reductase degrader, SR-12813, counteracts statin-induced upregulation of HMG-CoA reductase and augments the anticancer effect of atorvastatin. 2023. 677. 13-19
もっと見る
前のページに戻る